US 11596690
Stabilized formulations containing anti-IL-33 antibodies
granted A61KA61K39/39591A61K47/12
Quick answer
US patent 11596690 (Stabilized formulations containing anti-IL-33 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K39/39591, A61K47/12, A61K47/18, A61K47/183